Chris Gerardi is a faculty member of the conference speaking on the panel titled “Tailoring Remedies to the Misappropriation: Equitable Relief, Damages, or Both.”
CRA is a proud sponsor of this event.
For more information on this event, click here.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...